Jason C. Jones - 17 Feb 2022 Form 4/A Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Operating Officer
Signature
/s/ Jerome Wong (as Attorney-in-Fact)
Issuer symbol
EKSO
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4/A
Filing time
04 Apr 2024, 21:21:51 UTC
Date Of Original Report
15 Jun 2023
Previous filing
07 Apr 2022
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +3,446 +301% $0.000000 4,591 17 Feb 2022 By 401(k) F1
transaction EKSO Common Stock Award $0 +10,800 +235% $0.000000 15,391 12 Jun 2023 By 401(k) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently.